Drug dependence and the endogenous opioid system

European Neuropsychopharmacology

Volumn 13, Issue 6, 2003, Pages 424-434

  Gerrits, Mirjam A F M ^a   Lesscher, Heidi B M ^a   Van Ree, Jan M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Addiction; Brain circuits; Endogenous opioids; Gene knockout animals; Opioid receptors; Polymorphisms

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ALCOHOL; BENZODIAZEPINE DERIVATIVE; BETA ENDORPHIN; BUPRENORPHINE; COCAINE; DELTA OPIATE RECEPTOR; DIAMORPHINE; DRONABINOL; DYNORPHIN; ENKEPHALIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KETAZOCINE; METHADONE; MORPHINE; MORPHINE DERIVATIVE; MU OPIATE RECEPTOR; NALOXONE; NALTREXONE; NICOTINE; NOCICEPTIN; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE PEPTIDE; OPIATE RECEPTOR; PETHIDINE; PSYCHOSTIMULANT AGENT; UNINDEXED DRUG;

ALCOHOL CONSUMPTION; ANALGESIA; ANALGESIC ACTIVITY; BRAIN; COCAINE DEPENDENCE; DISEASE COURSE; DISEASE MODEL; DRUG ABUSE; DRUG BINDING SITE; DRUG DEPENDENCE; DRUG SELF ADMINISTRATION; DRUG TOLERANCE; DRUG USE; DRUG WITHDRAWAL; EUPHORIA; EXPERIMENTAL ANIMAL; GENETICS; HABIT; HISTORY; HUMAN; KNOCKOUT GENE; KNOCKOUT MOUSE; LIMBIC CORTEX; NONHUMAN; PAIN; PAPAVER SOMNIFERUM; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN VARIANT; REINFORCEMENT; REVIEW; REWARD; SINGLE NUCLEOTIDE POLYMORPHISM; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME;

EID: 0344876646     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2003.08.003     Document Type: Article

References (95)

1. Akil H., Mayer D.J., Liebeskind J.C. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science. 191:1976;961-962.
2. Akil H., Watson S.J., Young E., Lewis M.E., Khachaturian H., Walker J.M. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7:1984;223-255.
3. Altshuler H.L., Phillips P.E., Feinhandler D.A. Alteration of ethanol self-administration by naltrexone. Life Sci. 26:1980;679-688.
4. Becker A., Grecksch G., Brodemann R., Kraus J., Peters B., Schroeder H., Thiemann W., Loh H.H., Hollt V. Morphine self-administration in mu-opioid receptor-deficient mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 361(6):2000;584-589.
5. Becker A., Grecksch G., Kraus J., Loh H.H., Schroeder H., Hollt V. Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 365(4):2002;296-302.
6. Belluzzi J.D., Stein L. Enkephalin may mediate euphoria and drive-reduction reward. Nature. 266:1977;556-558.
7. Berrendero F., Kieffer B.L., Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J. Neurosci. 22(24):2002;10935-10940.
8. Bolles R.C. Theory of Motivation. 1975;Harper and Row, New York.
9. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., Tischfield J.A., Kreek M.J., Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl. Acad. Sci. U. S. A. 95(16):1998;9608-9613.
10. Bradbury A.F., Smyth D.G., Snell C.R., Birdsall N.J.M., Hulme E.C. C-fragment of lipotropin has a high affinity for brain opiate receptors. Nature. 260:1976;793-795.
11. Buchsbaum M.S., Davis G.C., Bunney W.E. Jr. Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature. 270:1977;620-622.
12. Contarino A., Picetti R., Matthes H.W., Koob G.F., Kieffer B.L., Gold L.H. Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice. Eur. J. Pharmacol. 446(1-3):2002;103-109.
13. De Vry J., Donselaar I., Van Ree J.M. Food deprivation and acquisition of cocaine self-administration in rats: effect of naltrexone and haloperidol. J. Pharmacol. Exp. Ther. 251:1989;735-740.
14. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38(2):1995;95-137.
15. Evans C.J., Keith D.E. Jr., Morrison H., Magendzo K., Edwards R.H. Cloning of a δ opioid receptor by functional expression. Science. 258:1992;1952-1955.
16. Everitt B.J., Dickinson A., Robbins T.W. The neuropsychological basis of addictive behaviour. Brain Res. Rev. 36(2-3):2001;129-138.
17. Fukuda A., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., Sugimoto T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1995;42-46.
18. Gerrits M.A.F.M., Patkina N., Zvartau E.E., Van Ree J.M. Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats. Psychopharmacology. 119:1995;92-98.
19. Gerrits M.A.F.M., Wiegant V.M., Van Ree J.M. Endogenous opioids implicated in the dynamics of experimental drug addiction: an in vivo autoradiographic analysis. Neuroscience. 89(4):1999;1219-1227.
20. Gerrits M.A.F.M., Petromilli P., Westenberg H.G., Di Chiara G., Van Ree J.M. Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats. Brain Res. 924(2):2002;141-150.
21. Ghozland S., Matthes H.W., Simonin F., Filliol D., Kieffer B.L., Maldonado R. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J. Neurosci. 22(3):2002;1146-1154.
22. Goeders N.E., Lane J.D., Smith J.E. Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol. Biochem. Behav. 20(3):1984;451-455.
23. Goldstein A., Lowney L.I., Pal B.K. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. U. S. A. 68:1971;1742-1747.
24. Goldstein A., Tachibana S., Lowney L.I., Hunkapiller M., Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. U. S. A. 76:1979;6666-6670.
25. Goldstein A., Fischli W., Lowney L.I., Hunkapiller M., Hood L. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc. Natl. Acad. Sci. U. S. A. 78:1981;7219-7223.
26. Grisel J.E., Mogil J.S., Grahame N.J., Rubinstein M., Belknap J.K., Crabbe J.C., Low M.J. Ethanol oral self-administration is increased in mutant mice with decreased beta-endorphin expression. Brain Res. 835(1):1999;62-67.
27. Hall F.S., Sora I., Uhl G.R. Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology. 154(1):2001;43-49.
28. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 258:1975;577-580.
29. Hull C.L. Principles of Behavior. 1943;Appleton-Century-Crofts, New York.
30. Hutcheson D.M., Matthes H.W., Valjent E., Sanchez-Blazquez P., Rodriguez-Diaz M., Garzon J., Kieffer B.L., Maldonado R. Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice. Eur. J. Neurosci. 13(1):2001;153-161.
31. Jacob J.J., Tremblay E.C., Colombel M.C. Enhancement of nociceptive reactions by naloxone in mice and rats. (author's translation) Psychopharmacologia. 37:1974;217-223.
32. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:1992;483-488.
33. Kakidani H., Furutani Y., Takahashi H., Noda M., Morimoto Y., Hirose T., Asai M., Inayama S., Nakanishi S., Numa S. Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor. Nature. 298:1982;245-249.
34. Khachaturian H., Lewis E.J., Schafer M.K., Watson S.J. Anatomy of the CNS opioid systems. Trends Neurosci. 3:1985;111-119.
35. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U. S. A. 89:1992;12048-12052.
36. Knapp R.J., Malatynska E., Collins N., Fang L., Wang J.Y., Hruby V.J., Roeske W.R., Yamaura H.I. Molecular biology and pharmacology of cloned opioid receptors. FASEB J. 9:1995;516-525.
37. Koenig H.N., Olive M.F. Ethanol consumption patterns and conditioned place preference in mice lacking preproenkephalin. Neurosci. Lett. 325(2):2002;75-78.
38. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 24(2):2001;97-129.
39. Kornet M., Goosen C., Van Ree J.M. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology. 104:1991;367-376.
40. Kosterlitz H.W., Waterfield A.A. In vitro models in the study of structure-activity relationships of narcotic analgesics. Annu. Rev. Pharmacol. 15:1975;29-47.
41. Kuzmin A., Semenova S., Zvartau E.E., Van Ree J.M. Enhancement of morphine self-administration in drug naive, inbred strains of mice by acute emotional stress. Eur. Neuropsychopharmacol. 6:1996;63-68.
42. Kuzmin A.V., Gerrits M.A.F.M., Van Ree J.M., Zvartau E.E. Naloxone inhibits the reinforcing and motivational aspects of cocaine addiction in mice. Life Sci. 60:1997;PL257-PL264.
43. Kuzmin A.V., Semenova S., Gerrits M.A.F.M., Zvartau E.E., Van Ree J.M. K-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur. J. Pharmacol. 321:1997;265-271.
44. Kuzmin A., Gerrits M.A.F.M., Zvartau E.E., Van Ree J.M. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of i.v. self-administration of cocaine in naive rats. Eur. Neuropsychopharmacol. 10(6):2000;447-454.
45. Lachowitz J.E., Shen Y., Monsma F.J. Jr., Sibley D.R. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J. Neurochem. 64:1995;34-40.
46. LaForge K.S., Yuferov V., Kreek M.J. Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur. J. Pharmacol. 410(2-3):2000;249-268.
47. Lasagna L. Drug interaction in the field of analgesic drugs. Proc. R. Soc. Med. 58:1965;978-983.
48. Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., Wei L.N. mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Mol. Brain Res. 54(2):1998;321-326.
49. Lord J.A., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides: μltiple agonists and receptors. Nature. 267:1977;495-499.
50. Markou A., Weiss F., Gold L.H., Caine S.B., Schulteis G., Koob G.F. Animal models of drug craving. Psychopharmacology (Berl.). 112:1993;163-182.
51. Martin A., Pilotto R., Singer G., Oei T.P. The suppression of ethanol self-injection by buprenorphine. Pharmacol. Biochem. Behav. 19:1983;985-986.
52. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 383(6603):1996;819-823.
53. Meunier J.-C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
54. Mollereau C., Parmentier M., Mailleux P., Butour J.-L., Moisnad C., Chalon P., Caput D., Vassart G., Meunier J.-C. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
55. Nakanishi S., Inoue A., Kita T., Nakaura M., Chang A.C., Cohen S.N., Numa S. Nucleotide sequence of cloned cDNA for bovine corticotropin-β- lipotropin precursor. Nature. 278:1979;423-427.
56. Noda M., Furutani Y., Takahashi H., Toyosato M., Hirose T., Inayama S., Nakanishi S., Numa S. Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin. Nature. 295:1982;202-206.
57. Pert C.B., Snyder S.H. Opiate receptor: demonstration in nervous tissue. Science. 179:1973;1011-1014.
58. Ramsey N., Van Ree J.M. Emotional but not physical stress enhances intravenous cocaine self-administration in drug-naive rats. Brain Res. 608:1993;216-222.
59. Ramsey N.F., Niesink R.J., Van Ree J.M. Prenatal exposure to morphine enhances cocaine and heroin self-administration in drug-naive rats. Drug Alcohol Depend. 33:1993;41-51.
60. Ramsey N.F., Gerrits M.A.F.M., Van Ree J.M. Naltrexone affects cocaine self-administration in naive rats through the ventral tegmental area rather than dopaminergic target regions. Eur. Neuropsychopharmacol. 9(1-2):1999;93-99.
61. Rankin H., Hodgson R., Stockwell T. The concept of craving and its measurement. Behav. Res. Ther. 17(4):1979;389-396.
62. Rawson R.A., McCann M.J., Hasson A.J., Ling W. Addiction pharmacotherapy 2000: new options, new challenges. J. Psychoact. Drugs. 32(4):2000;371-378.
63. Reid L.D., Hunter G.A. Morphine and naloxone modulate intake of ethanol. Alcohol. 1:1984;33-37.
64. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
65. Reisine T., Bell G.I. Molecular biology of opioid receptors. Trends NeuroSci. 16:1993;506-510.
66. Roberts A.J., McDonald J.S., Heyser C.J., Kieffer B.L., Matthes H.W., Koob G.F., Gold L.H. mu-Opioid receptor knockout mice do not self-administer alcohol. J. Pharmacol. Exp. Ther. 293(3):2000;1002-1008.
67. Roberts A.J., Gold L.H., Polis I., McDonald J.S., Filliol D., Kieffer B.L., Koob G.F. Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin. Exp. Res. 25(9):2001;1249-1256.
68. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
69. Schuller A.G., King M.A., Zhang J., Bolan E., Pan Y.X., Morgan D.J., Chang A., Czick M.E., Unterwald E.M., Pasternak G.W., Pintar J.E. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat. Neurosci. 2(2):1999;151-156.
70. Schulteis G., Koob G.F. Reinforcement processes in opiate addiction: a homeostatic model. Neurochem. Res. 21:1996;1437-1454.
71. Sertürner F.W.A. Darstellung der reinen Mohnsäure (Opiumsäure), nebst einer chemischen Untersuchung des Opiums. J. Pharmacol. 14:1806;47-93.
72. Shalev U., Grimm J.W., Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharm. Rev. 54:2002;1-42.
73. 3H) etorphine to rat-brain homogenate. Proc. Natl. Acad. Sci. U. S. A. 70:1973;1947-1949.
74. Skinner B.F. The Behavior of Organisms. 1938;Appleton-Century-Crofts, New York.
75. Sora I., Funada M., Uhl G.R. The mu-opioid receptor is necessary for [D-Pen2, D-Pen5]enkephalin-induced analgesia. Eur. J. Pharmacol. 324(2-3):1997;R1-R2.
76. Spragg S.D.S. Morphine addiction in chimpanzees. Comp. Psychol. Monogr. 15:1940;79-132.
77. Stewart J., De Wit H., Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol. Rev. 91:1984;251-268.
78. 8-vasopressin. Biochem. Biophys. Res. Commun. 161:1989;221-228.
79. Sweep C.G., Van Ree J.M., Wiegant V.M. Characterization of β-endorphin-imunoreactivity in limbic brain structures of rats self-administering heroin or cocaine. Neuropeptides. 12:1988;229-236.
80. Szeto C.Y., Tang N.L., Lee D.T., Stadlin A. Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. NeuroReport. 12(6):2001;1103-1106.
81. Terenius L. Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. Acta Pharmacol. Toxicol. (Copenh.). 32:1973;317-320.
82. Terenius L., Wahlström A. Inhibitor(s) of narcotic receptor binding in brain extracts and cerebrospinal fluid. Acta Pharmacol. 35(Suppl. 1):1974;15.
83. Tian M., Broxmeyer H.E., Fan Y., Lai Z., Zhang S., Aronica S., Cooper S., Bigsby R.M., Steinmetz R., Engle S.J., Mestek A., Pollock J.D., Lehman M.N., Jansen H.T., Ying M., Stambrook P.J., Tischfield J.A., Yu L. Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J. Exp. Med. 185(8):1997;1517-1522.
84. Tsuang M.T., Lyons M.J., Meyer J.M., Doyle T., Eisen S.A., Goldberg J., True W., Lin N., Toomey R., Eaves L. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch. Gen. Psychiatry. 55(11):1998;967-972.
85. Uhl G.R., Childers S.R., Pasternak G.W. An opiate-receptor gene family reunion. Trends Neurosci. 17:1994;89-93.
86. Van den Berg C.L., Kitchen I., Gerrits M.A.F.M., Spruijt B.M., Van Ree J.M. Morphine treatment during juvenile isolation increases social activity and opioid peptides release in the adult rat. Brain Res. 830(1):1999;16-23.
87. Van den Berg C.L., Van Ree J.M., Spruijt B.M., Kitchen I. Effects of juvenile isolation and morphine treatment on social interactions and opioid receptors in adult rats: behavioural and autoradiographic studies. Eur. J. Neurosci. 11(9):1999;3023-3032.
88. Van Ree J.M., Ramsey N. The dopamine hypothesis of opiate reward challenged. Eur. J. Pharmacol. 134:1987;239-243.
89. Van Ree J.M., Slangen J.L., De Wied D. Intravenous self-administration of drugs in rats. J. Pharmacol. Exp. Ther. 204:1978;547-557.
90. Van Ree J.M., Smyth D.G., Colpaert F.C. Dependence creating properties of lipotropin C-fragment (β-endorphin): evidence for its internal control of behavior. Life Sci. 24:1979;495-502.
91. Van Ree J.M., Gerrits M.A.F.M., Vanderschuren L.J. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol. Rev. 51(2):1999;341-396.
92. Wand G.S., McCaul M., Yang X., Reynolds J., Gotjen D., Lee S., Ali A. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology. 26(1):2002;106-114.
93. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.
94. Zadina J.E., Hackler L., Ge L.J., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502.
95. Zimmer A., Valjent E., Konig M., Zimmer A.M., Robledo P., Hahn H., Valverde O., Maldonado R. Absence of delta-9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. J. Neurosci. 21(23):2001;9499-9505.